Li Qiang presided over the executive meeting of the State Council and approved the Implementation Plan for Supporting the Development of Innovative Drugs throughout the Entire Industrial Chain. The meeting pointed out that the development of innovative drugs is related to the development of the pharmaceutical industry and the people's health and well-being. It is necessary to strengthen policy safeguards in the whole chain, coordinate the use of policies such as price management, medical insurance payment, commercial insurance, drug equipment and use, investment and financing, optimize the review and approval and medical institution assessment mechanisms, and work together to promote the breakthrough development of innovative drugs. It is necessary to mobilize various scientific and technological innovation resources, strengthen basic research on new drug creation, and consolidate the foundation of China's innovative drug development.
国常会审议通过《全链条支持创新药发展实施方案》
The State Council has approved the Implementation Plan for Supporting the Development of Innovative Drugs throughout the Entire Industrial Chain.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.